Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Feb 20;423(2):175-86.
doi: 10.1016/j.virol.2011.12.001. Epub 2011 Dec 29.

The lectins griffithsin, cyanovirin-N and scytovirin inhibit HIV-1 binding to the DC-SIGN receptor and transfer to CD4(+) cells

Affiliations

The lectins griffithsin, cyanovirin-N and scytovirin inhibit HIV-1 binding to the DC-SIGN receptor and transfer to CD4(+) cells

Kabamba B Alexandre et al. Virology. .

Abstract

It is generally believed that during the sexual transmission of HIV-1, the glycan-specific DC-SIGN receptor binds the virus and mediates its transfer to CD4(+) cells. The lectins griffithsin (GRFT), cyanovirin-N (CV-N) and scytovirin (SVN) inhibit HIV-1 infection by binding to mannose-rich glycans on gp120. We measured the ability of these lectins to inhibit both the HIV-1 binding to DC-SIGN and the DC-SIGN-mediated HIV-1 infection of CD4(+) cells. While GRFT, CV-N and SVN were moderately inhibitory to DC-SIGN binding, they potently inhibited DC-SIGN-transfer of HIV-1. The introduction of the 234 glycosylation site abolished HIV-1 sensitivity to lectin inhibition of binding to DC-SIGN and virus transfer to susceptible cells. However, the addition of the 295 glycosylation site increased the inhibition of transfer. Our data suggest that GRFT, CV-N and SVN can block two important stages of the sexual transmission of HIV-1, DC-SIGN binding and transfer, supporting their further development as microbicides.

PubMed Disclaimer

Figures

Figure 1
Figure 1. DC-SIGN receptor expression on Raji/DC-SIGN cells
(A) Raji/DC-SIGN and Raji cells were stained with phycoerythrin (PE)-labeled mouse anti-human CD209 (DC-SIGN) and analyzed by flow cytometry. DC-SIGN expression is shown beneath the bar labeled M1. (B) HIV-1 subtype B, QH0692.42 and subtype C, COT6.15 were captured by Raji/DC-SIGN and Raji cells at 3 different cell concentrations. The amount of captured virus was measured by p24 ELISA. (C) Inhibition of HIV-1 binding to Raji/DC-SIGN cells by mouse anti-human CD209 antibody. The amount of captured virus was measured by p24 ELISA.
Figure 2
Figure 2. Preincubation of HIV-1 with GRFT, CV-N and SVN inhibited binding to the DC-SIGN receptor
HIV-1 was incubated with GRFT, CV-N and SVN prior to capture on Raji/DC-SIGN cells. Bound virus was lysed and the amount of captured p24 was measured by ELISA. Bars represent mean ± SD of three different experiments. Untreated controls are shown in black.
Figure 3
Figure 3. Effects of 234 and 295 glycans on GRFT, CV-N and SVN inhibition of HIV-1 binding to the DC-SIGN receptor
(A) CAAN5342.A2 and (B) CAP63.A9J mutants lacking 234N and 295N were captured with Raji/DC-SIGN cells in the presence of GRFT, CV-N and SVN. The amount of bound virus was measured by p24 ELISA. Bars represent mean ± SD of three different experiments. Untreated controls are shown in black. The highest percentage inhibition obtained with each lectin is show next to the graphs.
Figure 4
Figure 4. Inhibition of DC-SIGN mediated HIV-1 transfer by post and pre-DC-SIGN binding methods
(A) In the post-DC-SIGN binding method, HIV-1 subtype B QH0692.42 and subtype C COT9.6 were incubated with Raji/DC-SIGN cells prior to the addition of GRFT, CV-N and SVN and co-culture with TZM-bl cells. (B) In the pre-DC-SIGN binding method, the virus was first incubated with GRFT, CV-N and SVN prior to the addition of Raji/DC-SIGN cells and co-culture with TZM-bl cells. The inhibition of transfer for both methods was determined by measuring the RLU. Bars represent mean ± SD of three different experiments. Untreated controls are shown in black.
Figure 5
Figure 5. Comparison of IC50 values between the post, pre and the combined method using TZM-bl cells
GRFT, CV-N and SVN inhibition of HIV-1 (A) COT9.6, (B) CAP63.A9J, (C) CAAN5342.A2 and (D) QH0692.42 transfer to TZM-bl cells was tested using the post, pre and combined methods. The IC50 values obtained with each method were then compared. The values shown are average of three different experiments.
Figure 6
Figure 6. DC-SIGN-mediated HIV-1 transfer to PBMC is inhibited by GRFT, CV-N and SVN
HIV-1 subtype C infectious viruses SW7 and Du179 and subtype B QH0515 transfer to PBMC was inhibited with GRFT, CV-N and SVN using (A) the post and (B) pre-DC-SIGN binding methods. The inhibition of transfer was measured by p24 ELISA. Bars represent mean ± SD of three different experiments. Untreated controls are shown in black. Levels of p24 antigen in the absence of virus or lectins were below detection (not shown).
Figure 7
Figure 7. Comparison of IC80 values between the post, pre and combined methods in PBMC
SW7 (A) and QH0515 (B) transfer to PBMC was inhibited with GRFT, CV-N and SVN using the post, pre and combined methods. This was followed by the comparison of IC80 values obtained with each method. The values shown are average of three different experiments.

References

    1. Abdool Karim Q, Abdool Karim SS, Frohlich JA, Grobler AC, Baxter C, Mansoor LE, Kharsany AB, Sibeko S, Mlisana KP, Omar Z, Gengiah TN, Maarschalk S, Arulappan N, Mlotshwa M, Morris L, Taylor D. Effectiveness and safety of tenofovirgel an antiretroviral microbicide, for the prevention of HIV infection in women. Science. 2010;329(5996):1168–1174. - PMC - PubMed
    1. Alexandre KB, Gray ES, Lambson BE, Moore PL, Choge IA, Mlisana K, Karim SS, McMahon J, O'Keefe B, Chikwamba R, Morris L. Mannose-rich glycosylation patterns on HIV-1 subtype C gp120 and sensitivity to the lectins, Griffithsin, Cyanovirin-N and Scytovirin. Virology. 2010;402(1):187–196. - PMC - PubMed
    1. Alexandre KB, Gray ES, Pantophlet R, Moore PL, McMahon JB, Chakauya E, O'Keefe BR, Chikwamba R, Morris L. Binding of the mannose-specific lectin, griffithsin, to HIV-1 gp120 exposes the CD4-binding site. J Virol. 2011 - PMC - PubMed
    1. Balzarini J. Targeting the glycans of gp120: a novel approach aimed at the Achilles heel of HIV. Lancet Infect Dis. 2005;5(11):726–31. - PubMed
    1. Balzarini J, Van Damme L. Microbicide drug candidates to prevent HIV infection. Lancet. 2007;369:787–797. - PubMed

Publication types

MeSH terms